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ABSTRACT 
Air pollution in Tehran is considered as one of the most important factors threatening human health. High 
concentrations of pollutants have adverse effects on citizens and the environment. We calculated the relation 
between COPD and criteria air pollutants in Tehran, one of the most polluted cities in the world during 2005 to 
2014. 
Hourly data of pollutants include SO2, O3 and NO2 were taken from the Tehran environmental protection agency and 
Air Quality Control Company. The AirQ2,2,3 model that proposed by the WHO, is used to health impact assessment 
of pollutants in terms of hospital  admission due to  Chronic Obstructive Pulmonary Disease.  
Results indicated that the total cumulative number of cases due to hospital admission due to COPD in Tehran city 
from 2005 to 2014 for SO2, O3 and NO2 was 1806, 2941 and 2454 cases, respectively. The finding of this study 
showed that total mean of SO2, O3 and NO2 was higher than the standard concentration. By comparison with 
guideline and standards, annual concentration for SO2, O3 and NO2 was exceeded on standard level in during the 
study period. 
This study demonstrated that a high percentage of hospital admission due to Chronic Obstructive Pulmonary Disease 
resulting from these pollutants could be due to the high average concentration in the air of Tehran during 2005 to 
2014. So, authorities must apply the efforts and necessities actions based on comprehensive scientific researches to 
control air pollutants and abate their negative effects on human health. 
Key words: Air Pollution; Atmospheric Pollutants; Environment; Chronic Obstructive Pulmonary Disease; Health 
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INTRODUCTION 
Air pollution in Tehran is one of the health and 
environmental problems in many large cities of the 
world such as Tehran. Researches over the last two 
decades have determined that there is a direct 
relationship between air pollution and health of 
people [1-5]. Chronic obstructive pulmonary disease 
(COPD) is a chronic inflammatory airway disease 
that described by hypersecretion, cough and 
inflammatory cell influx and persistent airflow 
limitation [6,7]. According to the prediction and 
estimation of the World Health Organization, about 
80 million people have gotten moderate to severe 
COPD and 3 million people of them died of COPD in 
2005, which corresponds almost 5% of all deaths 
globally. Total deaths due to COPD are projected to 
increase by more than 30% in the next 10 years [8]. 
By the year 2020, it has been estimated that COPD 
will rank 5th among the conditions with a high 
burden to society [9]. The gaseous pollutants such as 
ozone (O3), nitrogen dioxide (NO2) and sulfur 
dioxide (SO2) are highly reactive oxidants and can 
cause COPD at high concentrations. Ozone is a 
pollutant which can cause respiratory and 
cardiovascular diseases, eye burning sensation and 
failure of immune defense against infectious diseases. 
The following formula represents the ozone 
formation on the surface of earth (lower layer of 
troposphere) [10].  
VOC+NOX+Heat+Sunlight → O3 
In general, ozone enters the body as the following 
explanation: The membranes are made of both 
proteins and lipids; therefore, they are the proper 
aims for the ozone attack. Researches on human and 
animals demonstrated that some pulmonary disorders 
and complications are caused by the ozone exposure. 
United States National Ambient Air Quality 
Standards have appointed 0.075 ppm as the highest 
daily maximum 8- hour ozone concentrations [11-
13]. The ozone effects as follows:  
1- Histological changes in bronchiolar epithelium 
when it is in long -term exposure to O3 
concentrations of 1 to 0.2 ppm. 
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 2- Changes in lungs function in communication with 
ozone concentrations of 0.3 ppm for two hours which 
is reversible after discontinuation of the contact.  
3- Changes in the lungs protein structure after one 
hour of contact with ozone. 
4- Creation Biochemical changes of lungs and 
another limbs after four hours of contact with ozone 
concentrations of 3 to 6 ppm. 
5- Increased capacity to bacterial infections in a 
three- hour impact with ozone concentration of 0.8 
ppm. 
6- Effect on expiratory volume [14-16]. Nitrogen 
dioxide (NO2) is a by-product of high-temperature 
fossil fuel combustion. It is a ubiquitous pollutant in 
urban environments as well as indoor environments 
coming from combustion sources [17]. NO2 also is an 
important marker of air quality. A recent review 
provided moderate evidence that long-term exposure 
to an annual mean concentration below 40 μg/m3 of 
this pollutant was correlated with harmful health 
effects such as respiratory diseases, hospital 
admissions and mortality [18]. Human activities 
represent the main sources of NO2, from automobile 
exhaust emissions to stationary sources such as fossil 
fuels, power plants, industrial boilers, waste 
incinerators and heating household devices; but the 
main source of nitrogen dioxide in the air is the gas 
emitted by the public transportations. NO2 
concentration varies from morning to night. The main 
sources of NO2 in the indoor environment are the 
natural gas primus and the smoke created by 
cigarettes. Acute short-term (one hour) effects and 
low concentrations have been observed in animals 
[19-21]. Sulfur dioxide is a colorless gas that released 
from burning of coal and diesel fuel. SO2 and 
particulates together form a major portion of the 
pollutant load in many cities. SO2 may cause 
irritation, decrease of visibility and some respiratory 
illness. Healthy personal experience branch 
construction at 1.6 ppm of SO2, for a very few 
minutes exposure at 8-12 ppm level throat irritation 
occurs. At 20 ppm, immediate cough and eye 
irritation happen. Even for exposure of SO2 at 400-
500 ppm is dangerous for life. Sulfur dioxide (SO2) 
harms human health by reacting with the humidity in 
the nose, nasal perforation and throat and this is the 
way in which it annihilate the nerves in the 
respiratory system present. When the concentration 
of SO2 is higher than the prescribed standards of the 
World Health Organization (WHO), it effects 
especially on those suffering from asthma, bronchitis, 
lung and cardiac problems [22]. Many of studies 
performed about air pollution in Tehran city that 
demonstrated high concentration for SO2, O3 and 
NO2. In study of Naddafi et al. annual average for 
SO2, O3 and NO2 in 2011-2012 89, 85 and 68 μg/m
3
 
were estimated. A large number of studies show that 
acute and chronic morbidity such as COPD are due to 
gaseous air pollutants. In a study by Gharechahi et al. 
, there was significant relationship between sulfur 
dioxide and hospital admission due to respiratory 
diseases in elderly group and COPDs (p< 0.001) [23]. 
Also Stieb et al.. (2009) showed how an increase of 
18.4 ppb level of O3 concentration was associated 
with an increase of emergency room visits for COPD 
3.7%(95%CI: 0.5% to7.9%) [24]. Tehran is a 
developed and industrialized city of Iran, with about 
450,000 people population. Its longitude and latitude 
are 51°25 E and 35°34 N respectively and its 
elevation is about 1000–1800 meters above sea level. 
Tehran is located in valleys and is surrounded on the 
north, northwest, east and southeast by high to 
medium (3800–1000 m) mountain ranges. The 
mountain range pauses the flow of the moist wind to 
the capital and prevents the air pollution from being 
carried away from the city. Thus, during winter, lack 
of wind and cold air causes the polluted air to be 
trapped within the city [25]. These concomitant 
conditions make Tehran one of the worst regions in 
the world for atmospheric pollution for many days 
exceeding air quality standards during each year [26]. 
As health endpoints in Tehran during a period of ten 
years has not been Evaluated. Therefore, the present 
study is aimed to evaluate Chronic Obstructive 
Pulmonary Disease (COPD) attributed to atmospheric 
O3, NO2, and SO2 in Tehran City, during 2005-2014 
year. 
 
MATERIALS AND METHODS 
This study was a descriptive–analytic and AirQ 2.2.3 
software were used to Evaluation of Chronic 
Obstructive Pulmonary Disease (COPD) attributed to 
atmospheric O3, NO2, and SO2 in Tehran city. 
Location of Tehran is shown in Fig. 1. 
Hourly data of pollutants were collected from Tehran 
environmental protection agency and Air Quality 
Control Company. These data were on volumetric 
base, but AirQ software has been designed on 
gravimetric base, so we obtain data of pressure and 
temperature from I.R. of Iran meteorological 
organization and use following equation to convert 
ppb unit (DOE data) to µg/m
3
 unit (model required): 
  
  
 
  (    )       
       (  )
            (1) 
   Is molecular weight of pollutant, T is 
temperature as Kelvin degree and P is pressure.  
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Fig. 1: Map of Iran in the world and location of studied City (Tehran megacity) 
To determine the data validity for performing 
statistical analyzes, based on WHO criteria, the data 
recorded at weather stations were subjected to 
primary and secondary processing. In the primary 
processing, the exclusion of unnecessary data, sheet 
layout of the pollutants, and time standardization (to 
provide the median estimate) were performed and on 
the basis of WHO criteria, the number of weather 
stations with valid data were identified. In this 
regard, the ratio between the number of valid data for 
the 2 seasons (warm and cold season) should not be 
more than 2. Also, in order to achieve the median 24 
hour values, at least 50% data must exist with 
sufficient validity. 
For health impact quantification due to exposure with 
SO2, annual mean, winter and summer mean, annual 
98 percentile, annual maximum and winter and 
summer maximum was calculated in all years. All of 
these corrections, processing and required statistical 
parameters calculation were performed by using 
Microsoft Office Excel spread sheet. For all the 
pollutants, the parameters required by the software 
(annual and seasonal average, maximum and 
annual98th percentiles) were calculated. Hospital 
admission due to (COPD) related to O3, NO2, and 
SO2 by AirQ2.2.3 tool. AirQ 2.2.3 software was 
introduced by the WHO in 2004 and developed by 
the WHO European Center for Environment and 
Health, Bilthoven Division. This model is used to 
estimate the impacts of exposure to specific air 
pollutants on the health of people living in a certain 
period and area. The assessment is based on the 
attributable proportion (AP), defined as the fraction 
of the health outcome in a certain attributable 
population expose to a given atmospheric pollutant 
[27]. The AP can be calculated by the following 
equation 
AP=SUM {[RR(c)-1]p(c)}/SUM [RR(c)p(c)] (2) 
P(c) is the population of city and RR is the relative 
risk of health endpoints in category “C” of exposure 
that obtain from epidemiological study and exposure-
response functions.  
Relative Risk (RR) is defined as a ratio of the 
probability of the event when people exposure to 
probability of the event when people non-exposed. 
Rate of the health outcome attributable to the 
exposure (IE), calculated as follows: 
IE=I×AP                        (3) 
Where, (I) is the baseline frequency of the health 
outcome in the population under investigation 
(survey). Number of cases attributable to the 
exposure to pollutant (NE) with knowing size of 
population (N) can be calculated as following: 
NE=IE×N                      (4) 
Baseline incidence (BI) multiplied at population size 
and Attributable proportion (AP) then divided to 10
5
 
to obtain number of excess cases: 
 
 
(
                             
   
)                                                       (5) 
 
Finally after importing prepared data to AirQ 2.2.3 
Software, results present as the excess cases of 
hospital admission due to chronic obstructive 
pulmonary disease (COPD) attributed to Ozone (O3), 
Nitrogen dioxide (NO2) and Sulfur dioxide (SO2) 
pollutant in ten years.  
 
RESULTS AAND DISCUSSIONS 
The Annual concentrations of pollutants 
The annual average maximum, summer average, 
winter average, and 98 percentiles of O3, NO2 and 
SO2 concentrations have been showed in Table 1. As 
can be seen in Table 2, among the-ten studied years, 
highest annual concentration of sulfur dioxide 
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(μg/m3) was reported in year 2008 and 2007, with 
mean value of 112 and 89 μg/m3, respectively. Iran 
national standards set and determined 20μg/m3 for 
annual mean of SO2, and according to these 
standards, all of the studied years exceeded by the 
national standard. During the study period of 2005-
2014, annual mean concentration of SO2 was 2.22, 
4.32, 4.49, 5.63, 4.13, 4.07, 2.98, 2.58, 2.02 and 1.96 
times higher than national standards, respectively 
(Fig.2). For nitrogen dioxide highest annual 
concentration (μg/m3) was reported in year 2008 and 
2007, with mean value of 205 and 166 μg/m3, 
respectively. WHO guideline [28] set and determined 
40μg/m3 for annual mean of NO2, that according to 
these standards, all of the studied years exceeded 
from national standard. During the study period, in 
2005-2014, annual mean concentration of NO2 was 
2.37, 2.72, 4.15, 5.13, 3.15, 3.28, 2.32, 2.15, 2.52 and 
2.4 times higher than standards, respectively (Fig.2). 
According to the table1 annual mean concentration of 
pollutants in 2008 to 2014 has a decreasing slope. 
This may be due to the reduction of sulfur in the fuel 
and increase of transport that use compressed natural 
gas (CNG) for gas up—albeit this point has been 
confirmed by Department of Environment (DOE) 
that those vehicles that use gasoline for gas up are 
responsible for SO2 pollution. Also these trends could 
be related to the control program (entering of new 
equipped vehicles with better fueling devices, using 
catalytic transformer in new vehicles and devices, 
and having compulsory standards of Euro 1 and 2 for 
under-constructing ones). In spite of increased levels 
of NO2 concentration, very low development was 
seen. Although, supervising plan in Tehran city was 
considered to use engines with better combustion and 
produce fewer NO2, and decreasing emission of NO2 
per mile study of Motesaddi Zarandi et al.  On Long-
term trends of Nitrogen oxides and surface ozone 
concentrations in Tehran city, 2002–2011confirm this 
finding [29]. Due to the large number of charts in ten 
years we preferred to show last year studied (2014) in 
Fig. 2. Fig 2 shows the percentage of time people in 
Tehran was exposed to different concentrations of 
pollutants during 2014. 
The highest number of days of exposure to NO2 in 
2014 was observed in the concentration category of 
80–89 and 90–99 μg/m3 which was higher than 
NAAQSs published standards for annual mean NO2. 
Also, the highest numbers of days of exposure to SO2 
and O3 concentrations were in the concentration 
range of 30–39, 40–09 and 70–79 μg/m3 in 21 March 
2014 to 20 March 2015. 
The baseline incidence and relative risks 
Cases of Hospital admissions due to chronic 
obstructive pulmonary disease (COPD) attribute to 
expose with SO2, O3, and NO2 Was estimated by 
AirQ2.2.3 model in ten years in Tehran. Baseline 
incidence (BI) and relative risks with 95% confidence 
intervals (95% CI) that used for the health effect 
estimation in present study are shown in table 2. 
Relative risks and BI used in this study based on 
other studies conducted in Iran [25,30] and compared 
with that of World Bank [31] and World health 
statistics 2013 [32] to make sure for accuracy and 
precision. The average BI was about 5 per1000 
people for Iran due to having young population. 
According to the results of table 2, with increasing 
each 10 µg/m
3
 concentration of SO2, O3, NO2, risk of 
HA-COPD increased 0.44% (1 per CI= 0.05 and 1.01 
per CI= 0.95), 0.58% (1.0022 per CI= 0.05 and 
1.0094 per CI= 0.95) and 0.64% (1.0006 per CI= 
0.05 and 1.0044per CI= 0.95) respectively. Indicators 
of relative risk (RR) and Attributable Proportion (AP) 
for COPD to NO2 is defined on base- line Incidence 
(BI) 101.4 at 10
5
 persons by the WHO. 
Cases of hospital admission du exposure to SO2, 
O3, NO2 pollutants  
Number of excess cases of hospital admission due to 
COPD due to short-term exposure above 10µg/m
3
 for 
SO2, O3, and NO2 in ten years estimated that showed 
in Table 3. Results showed, total cumulative number 
of cases due to HA-COPD estimated in the present 
study for ten years SO2, O3 and NO2 was 1806, 2941 
and 2454 cases in central RR in a year, respectively. 
As seen in table 4, with regard to AP and exposed 
population, maximum number of extra hospital 
admission due to COPD for NO2 among investigated 
years belonged to the year 2008 with 388 cases. Also 
maximum number of excess hospital admission due 
to COPD for O3 among investigated years belonged 
to 2008 with 414 cases. Finally maximum number of 
excess hospital admission due to COPD for SO2 
among investigated years belonged to the year 2007 
with 293 cases. Results the study conducted in 
Tehran by Naddafi and et al.  [25] showed number of 
excess cases attributed to NO2, SO2, and O3 in with 
percentage of attributable proportion (AP) 2.79, 3.38 
and 4.80, was 247, 298 and 424 cases respectively. 
Ghanbari and et al.  studied quantification of the 
health effect of COPD from exposure to NO2, SO2, 
and O3 in Tabriz in 2009 [33] and results of this study 
showed that attributable proportion, and number of 
persons suffering from COPD due to O3, NO2, and 
SO2 exposure (BI=101.4 per105 persons) was 2.9%, 
0.89%, 0.41%, 44, 13 and 6 cases, respectively. The 
results of both studies are somewhat close together in 
metropolitan of Tabriz is very similar with and this 
study in mega city of Tehran, Iran. The results of 
another study in Europe, the APHEA project (a Meta 
centric and multi-pollutant study) evaluated air 
pollution (multi-pollutant) and its short-term effects 
such as HACOPD. The RR for a 50 μg/m3 in-crease 
in the daily mean level of pollutant was 1.02 
(95%CI0.98–1.06) for SO2, 1.02(95%CI1.00–1.05) 
for NO2 and 1.04 (95%CI1.02– 1.07) [25]. Other 
studies have been conducted in US cities, by Medina-
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Ramón et al.  (2006) (41) European cities, by 
Anderson et al.  (1997) [35] Milan (Italy) Fattore et 
al.  (2011) [34] and Hong Kong (China) Ko et al. 
[36].  On the health effects of atmospheric pollution, 
as this study has confirmed, they found there is 
association between gausses pollutants (O3, NO2 and 
SO2) and HA COPD, as well. Totally researches 
carried out in this issue showed convincing evidences 
from the role of pollutants in the incidence of COPD. 
In fact, various factors, such as smoking, 
occupational exposures, inappropriate diet, indoor air 
pollution, exposure to SO2, O3, and NO2 can 
influence incidence of COPDs, especially in elderly 
people, but exposure to air pollutants can exacerbate 
these diseases as predisposing factors [23].  
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Fig. 3: Compare of annual mean concentration of NO2 and 
SO2 with WHO Guideline 
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Table 1. Summary of required statistical parameters, O3, NO2, SO2, (μg/m
3) by means of the model (Tehran, Iran, 2005-2014) 
Year Pollutant 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 
 NO2 95 108 166 205 126 131 92 86 101 96 
Average annual SO2 44 86 89 112 82 81 59 51 40 39 
 O3 50 51 69 96 86 74 63 64 63 55 
 NO2 90 109 132 174 119 117 89 86 92 88 
Average summer SO2 39 59 49 122 64 78 51 48 37 35 
 O3 59 65 85 118 113 100 78 83 76 71 
 NO2 100 108 201 237 133 145 96 85 110 104 
Average winter SO2 49 114 131 102 101 85 67 54 43 43 
 O3 40 35 52 74 59 47 48 44 49 37 
 NO2 196 174 322 450 183 208 139 119 156 143 
98 percentiles annual SO2 101 213 208 207 146 165 95 75 68 68 
 O3 81 114 119 174 154 143 122 105 107 93 
 NO2 261 356 386 644 297 228 218 122 197 174 
Maximum annual SO2 123 330 258 312 181 219 110 90 81 94 
 O3 110 139 131 206 250 164 163 126 154 76 
 NO2 173 178 213 334 183 208 218 121 137 128 
Maximum summer SO2 59 118 85 206 103 121 84 67 54 53 
 O3 110 139 131 206 250 164 154 111 123 102 
 NO2 261 356 386 644 297 228 173 122 197 174 
Maximum winter SO2 123 330 258 312 181 219 110 90 81 94 
 O3 73 113 106 144 116 91 163 126 154 76 
 
Table 2: Baseline incidence and relative risks for HA- COPD of SO2, O3, NO2 in this study 
Pollutant Baseline incidence RR (95% CI) per 10 μg/m3 
NO2  
101.4 
1.0026(1.0006-1.0044) 
SO2 1.0044 (1–1.011) 
O3 1.0058(1.0022-1.0094) 
 
Table 3:  Number of cases Hospital admission and attributable proportion due to COPD in Tehran city, during 2005-2014 
Health end point (hospitalization) Year Pollutant 
AP 
(attributable 
proportion) 
No. of excess cases 
(uncertainty range) 
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2005 
NO2 2.17 (0.51-3.62) 178 (41-297) 
SO2 1.47 (0- 3.61) 121 (0-297) 
O3 2.27 (0.87-3.62) 186 (71-298) 
2006 
NO2 2.52 (0.59-4.19) 212 (50-353) 
SO2 3.02 (0- 7.23) 255 (0-610) 
O3 3.39 (1.76-5.04) 286 (149-425) 
2007 
NO2 4.02 (0.95-6.62) 344 (82-566) 
SO2 3.46 (0- 8.17) 293 (0-698) 
O3 3.34 (1.29-5.3) 285 (110-453) 
2008 
NO2 4.6 (1.10-7.55) 399 (95-655) 
SO2 1.35 (0- 3.32) 117 (0-288) 
O3 4.78 (1.86-7.52) 414 (162-652) 
2009 
NO2 2.92 (0.69-4.85) 257 (60-427) 
SO2 3.13 (0- 7.48) 276 (0-660) 
O3 4.29 (1.67-6.77) 377 (147-596) 
2010 
NO2 3.08 (0.73-5.11) 275 (65-456) 
SO2 1.67 (0- 3.91) 143 (0-349) 
O3 3.59 (1.39-5.7) 321 (124-509) 
 NO2 2.10 (0.49-3.51) 190 (44-318) 
2011 SO2 2.13 (0- 5.16) 193 (0-467) 
 O3 3.02 (1.16-4.81) 273 (105-435) 
 NO2 1.94 (0.45-3.24) 178 (41-297) 
2012 SO2 1.8 (0- 4.39) 166 (0-403) 
 O3 3.06 (1.18-4.87) 281 (108-447) 
 NO2 2.31 (0.54-3.85) 215 (50-359) 
2013 SO2 1.32 (0- 3.24) 123 (0-302) 
 O3 2.98 (1.15-4.75) 278 (107-442) 
2014 
NO2 2.18 (0.51-3.64) 206 (48-344) 
SO2 1.26 (0- 3.11) 119 (0-294) 
O3 2.54 (0.98-4.06) 240 (92-383) 
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CONCLUSIONS 
This study was the first survey to assess health 
impacts of air pollution in Tehran, Iran in the recent 
decade period year 2005 to 2014. Although the 
results of this study are in line with results from other 
studies, since the climate, demographic and 
geographic characteristics is different, there is still 
high need to further studies to specify local RRs and 
BIs instead of WHO defaults. According to WHO, 
COPD was estimated to be the 12th cause of 
disability and the sixth cause of mortality in 1990, 
and it is also estimated to be the 5th cause of 
disability and the third cause of mortality by 2020. 
Nitrogen dioxide, sulfur dioxide, and ozone has a 
significant impact on COPD hospitalization. This 
study applied the AirQ software assesses the health 
impact of air pollution for citizenship in Tehran, one 
of the most populated areas in the world, where the 
geographical features make the air quality among the 
worst in the world. As presented in this study, air 
quality affects daily hospital admissions dramatically. 
So authorities must apply the management schemes 
and comprehensive measures based on 
comprehensive scientific researches Such as 
Restriction of use of fossil resources, improving 
public transportation systems, traffic management 
quality of the auto industry productions and, etc, to 
control air pollutants and diminishing the health 
impacts on human health. The results convince urban 
air pollution authorities and governmental decision 
makers to conflict for finding optimized model about 
to anthropogenic sources and reduce air pollution 
concentrations and/or reduce exposure of people to 
air pollutants. 
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